Bausch Health Companies Inc (N:BHC)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BHC within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 2/20 Jun 30/20 Wechsler Amy B Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 375 $18.29
Jul 2/20 Jun 30/20 Robertson Russel C Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 2,050 $18.29
Jul 2/20 Jun 30/20 Paulson John Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 1,545 $18.29
Jul 2/20 Jun 30/20 De Schutter Richard U Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 1,750 $18.29
Jun 9/20 Jun 5/20 ValueAct Holdings, L.P. Indirect Ownership Common Shares, no par value P - Open market or private purchase 948,353 $19.24
Jun 9/20 Jun 5/20 ValueAct Holdings, L.P. Indirect Ownership Common Shares, no par value S - Open market or private sale -948,353 $19.24
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Common Shares, No Par Value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BHC within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 7th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 2/20 Jun 30/20 Wechsler Amy B Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 375 $18.29
Jul 2/20 Jun 30/20 Robertson Russel C Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 2,050 $18.29
Jul 2/20 Jun 30/20 Paulson John Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 1,545 $18.29
Jul 2/20 Jun 30/20 De Schutter Richard U Direct Ownership Common Shares, No Par Value A - Grant, award or other under Rule 16b-3(d) 1,750 $18.29
Jun 9/20 Jun 5/20 ValueAct Holdings, L.P. Indirect Ownership Common Shares, no par value P - Open market or private purchase 948,353 $19.24
Jun 9/20 Jun 5/20 ValueAct Holdings, L.P. Indirect Ownership Common Shares, no par value S - Open market or private sale -948,353 $19.24
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Non-qualified Stock Options (right To Purchase) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jun 1/20 Jun 1/20 Spurr Robert Direct Ownership Common Shares, No Par Value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BHC

Competitors

Competitors with Recent Insider Filings
Royalty Pharma plc (OQ:RPRX)
Emergent Biosolutions (N:EBS)
BridgeBio Pharma (OQ:BBIO)